

Cover Story
Conversation with The Cancer Letter
After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.
In Brief


Clinical Roundup


Drugs & Targets


NCI Trials


NCI Trials for April 2025
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- TIL + pembro regimen achieves 24% response rate in solid epithelial tumors, marking a step forward in immunotherapy research
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - In The Headlines: Are cancer registries on the chopping block, and what does it mean if they are?
- Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health
- Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI